203317-12-8

Basic information

• Product Name: 2-Cyano-3-(3,4-dichloro-phenyl)-3-phenyl-propionic acid ethyl ester
• Synonyms: 2-Cyano-3-(3,4-dichloro-phenyl)-3-phenyl-propionic acid ethyl ester
• CAS NO: 203317-12-8
• Molecular Weight: 348.229
• Mol File: 203317-12-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-Cyano-3-(3,4-dichloro-phenyl)-3-phenyl-propionic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Cyano-3-(3,4-dichloro-phenyl)-3-phenyl-propionic acid ethyl ester(203317-12-8)
• EPA Substance Registry System: 2-Cyano-3-(3,4-dichloro-phenyl)-3-phenyl-propionic acid ethyl ester(203317-12-8)

Safety Data

• Hazardous Substances Data: 203317-12-8(Hazardous Substances Data)

Upstream product

• 79175-35-2 3,4-dichlorophenylmagnesium bromide 
• 2025-40-3 ethyl benzylidenecyanoacetate 
• 100-52-7 benzaldehyde 
• 105-56-6 ethyl 2-cyanoacetate 
• 6287-38-3 3,4-dichlorobenzaldehyde 
• 108-86-1 bromobenzene 
• 55417-50-0 ethyl 2-cyano-3-(3,4-dichlorophenyl)-prop-2-enecarboxylate 

Downstream Products

• 96850-13-4 LNK 131 hydrochloride 
• 748724-48-3 LNK 131 
• 85663-59-8 1-[(1R,3R)-3-(3,4-Dichloro-phenyl)-indan-1-yl]-4-((E)-3-phenyl-allyl)-piperazine 
• 85663-58-7 1-[(1S,3R)-3-(3,4-Dichloro-phenyl)-indan-1-yl]-4-((E)-3-phenyl-allyl)-piperazine 
• 85663-57-6 3-{4-[(1S,3S)-3-(3,4-Dichloro-phenyl)-indan-1-yl]-piperazin-1-yl}-propan-1-ol 
• 80273-19-4 3-{4-[(1R,3S)-3-(3,4-Dichloro-phenyl)-indan-1-yl]-piperazin-1-yl}-propan-1-ol 
• 85663-56-5 2-{4-[(1S,3S)-3-(3,4-Dichloro-phenyl)-indan-1-yl]-piperazin-1-yl}-ethanol 
• 85663-55-4 2-{4-[(1R,3S)-3-(3,4-Dichloro-phenyl)-indan-1-yl]-piperazin-1-yl}-ethanol 
• 85663-54-3 (+)-cis-1-<3-(3,4-dichlorophenyl)indan-1-yl>-4-methylpiperazine 
• 85663-53-2 (+)-trans-1-<3-(3,4-dichlorophenyl)indan-1-yl>-4-methylpiperazine 
• 86939-07-3 1-Chloro-3-(3,4-dichloro-phenyl)-indan 
• 80272-59-9 cis-3-(3,4-dichlorophenyl)-2,3-dihydro-1H-inden-1-ol 
• 85662-98-2 3-(3',4'-dichlorophenyl)-indan-1-one 
• 80272-06-6 3-(3',4'-dichlorophenyl)-3-phenylpropanoic acid 

Relevant articles and documents

TREATMENT OF NEURODEGENERATIVE DISEASES USING INDATRALINE ANALOGS

Methods and compositions useful in the treatment or prevention of synucleinopathies, such as Parkinson''s disease, diffuse Lewy body disease, and multiple system atrophy, or other neurodegenerative diseases (e.g., amyotrophic lateral sclerosis, Huntington''s disease, and Alzheimer''s disease) are provided. The treatment including administering to a subject an indatraline derivative that inhibits the aggregation of a-synuclein.